Molecular 'Scissors' Designed to Halt HIV in Lab Cells

Scientists have engineered a groundbreaking 'molecular scissors' technology that demonstrates the potential to disable the Human Immunodeficiency Virus (HIV) within laboratory-controlled cellular environments. A research team, including scientists from the López-Neyra Institute of Parasitology and Biomedicine in Granada, Spain, and an international group from Amsterdam, successfully used the CRISPR-SaCas9 system to target and cut the HIV DNA integrated into infected cells. This precise dual-point cutting method removed a significant fragment of the viral genome, rendering the virus unable to repair itself or propagate. The technique proved highly effective, working in up to 97% of the treated cells and completely inactivating the virus in this experimental model. Researchers explained that HIV is particularly challenging to eradicate because it integrates silently into human DNA. The CRISPR approach aims to cut this integrated viral material, but the critical factor is ensuring the virus cannot escape or self-repair. Current antiretroviral therapies effectively block viral multiplication but do not eliminate these integrated copies, allowing the virus to reactivate if treatment stops. While this development represents a significant leap forward, it remains in the early stages. The research has so far only been demonstrated in vitro, meaning it is far from being applicable to patients. The next steps involve validating the strategy in ex vivo patient cells, testing it in humanized mouse models, and rigorously evaluating its safety. Scientists are also conducting extensive sequencing studies to ensure the tool does not cause unintended cuts in the human genome. Any potential transition to clinical trials is considered a long-term prospect, pending the successful completion of these preclinical phases.